LPL Financial’s Invesco Biotechnology & Genome ETF PBE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$4.93M Sell
76,895
-5,869
-7% -$376K ﹤0.01% 2314
2025
Q1
$5.25M Sell
82,764
-9,341
-10% -$593K ﹤0.01% 2105
2024
Q4
$6.13M Buy
92,105
+1,503
+2% +$100K ﹤0.01% 1900
2024
Q3
$6.33M Sell
90,602
-10,157
-10% -$709K ﹤0.01% 1790
2024
Q2
$6.53M Buy
100,759
+3,693
+4% +$239K ﹤0.01% 1650
2024
Q1
$6.28M Buy
97,066
+14,003
+17% +$906K ﹤0.01% 1618
2023
Q4
$5.47M Buy
83,063
+32,972
+66% +$2.17M ﹤0.01% 1627
2023
Q3
$2.86M Sell
50,091
-2,936
-6% -$167K ﹤0.01% 1997
2023
Q2
$3.25M Sell
53,027
-5,691
-10% -$349K ﹤0.01% 1851
2023
Q1
$3.69M Buy
58,718
+14,840
+34% +$931K ﹤0.01% 1697
2022
Q4
$2.79M Buy
43,878
+1,261
+3% +$80.1K ﹤0.01% 1823
2022
Q3
$2.51M Buy
42,617
+13,399
+46% +$790K ﹤0.01% 1808
2022
Q2
$1.69M Sell
29,218
-3,435
-11% -$198K ﹤0.01% 2154
2022
Q1
$2.03M Sell
32,653
-8,543
-21% -$530K ﹤0.01% 2048
2021
Q4
$2.93M Buy
41,196
+677
+2% +$48.2K ﹤0.01% 1807
2021
Q3
$3.03M Buy
40,519
+2,136
+6% +$160K ﹤0.01% 1732
2021
Q2
$2.97M Buy
38,383
+3,360
+10% +$260K ﹤0.01% 1688
2021
Q1
$2.59M Sell
35,023
-270
-0.8% -$19.9K ﹤0.01% 1652
2020
Q4
$2.48M Buy
35,293
+1,712
+5% +$120K ﹤0.01% 1529
2020
Q3
$1.9M Buy
33,581
+9,653
+40% +$546K ﹤0.01% 1488
2020
Q2
$1.39M Buy
23,928
+1,299
+6% +$75.7K ﹤0.01% 1581
2020
Q1
$1.05M Buy
22,629
+1,356
+6% +$63K ﹤0.01% 1579
2019
Q4
$1.19M Sell
21,273
-1,508
-7% -$84.2K ﹤0.01% 1704
2019
Q3
$1.08M Sell
22,781
-5,678
-20% -$269K ﹤0.01% 1676
2019
Q2
$1.52M Sell
28,459
-8,916
-24% -$477K ﹤0.01% 1416
2019
Q1
$2.06M Sell
37,375
-157
-0.4% -$8.67K ﹤0.01% 1175
2018
Q4
$1.77M Sell
37,532
-1,655
-4% -$77.9K ﹤0.01% 1133
2018
Q3
$2.33M Sell
39,187
-286
-0.7% -$17K 0.01% 1078
2018
Q2
$2.16M Buy
39,473
+578
+1% +$31.6K 0.01% 1085
2018
Q1
$1.91M Sell
38,895
-3,164
-8% -$156K 0.01% 1133
2017
Q4
$1.98M Buy
42,059
+34
+0.1% +$1.6K 0.01% 1055
2017
Q3
$2.1M Buy
42,025
+58
+0.1% +$2.9K 0.01% 962
2017
Q2
$1.92M Sell
41,967
-9,420
-18% -$430K 0.01% 960
2017
Q1
$2.15M Sell
51,387
-1,888
-4% -$79.1K 0.01% 796
2016
Q4
$2.1M Sell
53,275
-5,856
-10% -$231K 0.02% 772
2016
Q3
$2.48M Sell
59,131
-2,758
-4% -$115K 0.02% 659
2016
Q2
$2.38M Sell
61,889
-82,434
-57% -$3.17M 0.02% 676
2016
Q1
$5.72M Sell
144,323
-35,053
-20% -$1.39M 0.02% 654
2015
Q4
$8.68M Buy
179,376
+88,740
+98% +$4.3M 0.02% 492
2015
Q3
$4.36M Sell
90,636
-7,448
-8% -$359K 0.02% 513
2015
Q2
$5.72M Buy
98,084
+11,707
+14% +$682K 0.03% 463
2015
Q1
$4.79M Buy
86,377
+11,794
+16% +$654K 0.02% 534
2014
Q4
$3.74M Buy
74,583
+12,090
+19% +$607K 0.02% 606
2014
Q3
$2.87M Buy
62,493
+718
+1% +$33K 0.02% 687
2014
Q2
$2.7M Sell
61,775
-29,222
-32% -$1.28M 0.02% 724
2014
Q1
$3.79M Buy
90,997
+6,207
+7% +$258K 0.02% 541
2013
Q4
$3.14M Buy
84,790
+13,699
+19% +$507K 0.02% 614
2013
Q3
$2.45M Buy
71,091
+27,470
+63% +$947K 0.02% 680
2013
Q2
$1.26M Buy
+43,621
New +$1.26M 0.01% 972